(VIANEWS) – Shares of Pacific Biosciences of California (NASDAQ Composite: PACB) dropped 6.91% to $25.18 at 03:43 EST on Friday, following the last session’s downward trend. NASDAQ Composite is rising 0.45% to $15,993.71, following the last session’s upward trend. This seems, at the moment, a somewhat positive trend exchanging session today.

Pacific Biosciences of California’s last close was $27.05, 49.62% below its 52-week high of $53.69.

Volume

Today’s last reported volume for Pacific Biosciences of California is 2029854 which is 7.9% above its average volume of 1881155.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 63.1% for the ongoing quarter and 39.6% for the next. The company’s growth estimates for the present quarter and the next is a negative 50% and a negative 164.9%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 79.2%, now sitting on 105.83M for the twelve trailing months.

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $25.18 at 03:43 EST, way under its 52-week high of $53.69 and way higher than its 52-week low of $14.07.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s value is under its 50-day moving average of $26.06 and way below its 200-day moving average of $28.37.

More news about Pacific Biosciences of California (PACB).

LEAVE A REPLY

Please enter your comment!
Please enter your name here